stockrow
Saturday 7 November 2026
Export CIM’s income statement to Excel — free account
Chimera Investment Corporation
Chimera Investment Corporation’s revenue for fiscal 2025 (year ended December 2025) was $821.3 million, up 7.94% from fiscal 2024.
- Revenue
- +10.3%
- EPS
- −755.6%
- Free cash flow
- −191.2%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
7.28
0.64
−8.08%
Follow CIM
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 2 | 2 | — |
| 5.67% | (2.60%) | (3.35%) | (10.81%) | ||
| 1.00% | (0.46%) | (0.55%) | (1.61%) | ||
ROIC |
1.25% | 0.57% | 0.40% | 0.00% | |
Return on Tangible Assets |
(2.48%) | 1.01% | 1.15% | 0.00% | |
Average Days of Receivables |
51.54 | 49.87 | 46.92 | 0.00 | |
Free Cash Flow per Share |
(3.03) | (0.65) | (4.61) | (7.74) | |
Free Cash Flow |
(248.88) | (54.36) | (386.15) | (649.01) | |
| Other line items | |||||
Cash ROIC |
(1.56%) | (0.35%) | (2.37%) | (25.68%) | |
Accounts Receivable Turnover |
8.32 | 8.49 | 9.33 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.01) | 0.09 | (2.15) | (0.02) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.56% | 12.42% | 14.21% | 15.59% | |
Share Based Compensation of Revenue |
1.18% | 1.02% | 1.09% | 1.15% | |
Operating CF/Net income |
(1.72) | 0.82 | 4.57 | 2.53 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | — | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Revenue per Share |
10.00 | 10.16 | 10.38 | 10.63 | |
Operating CF per Share |
(3.03) | (0.65) | (4.61) | (7.74) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026